BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23085163)

  • 1. Molecular dynamics simulation of the interaction between protein tyrosine phosphatase 1B and aryl diketoacid derivatives.
    Wang Q; Gao J; Liu Y; Liu C
    J Mol Graph Model; 2012 Sep; 38():186-93. PubMed ID: 23085163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing interaction requirements in PTP1B inhibitors: a comparative molecular dynamics study.
    Kumar R; Shinde RN; Ajay D; Sobhia ME
    J Chem Inf Model; 2010 Jun; 50(6):1147-58. PubMed ID: 20455572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.
    Liu S; Zeng LF; Wu L; Yu X; Xue T; Gunawan AM; Long YQ; Zhang ZY
    J Am Chem Soc; 2008 Dec; 130(50):17075-84. PubMed ID: 19012396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling.
    Cui W; Cheng YH; Geng LL; Liang DS; Hou TJ; Ji MJ
    J Chem Inf Model; 2013 May; 53(5):1157-67. PubMed ID: 23621621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
    Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
    Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis of Fullerene Derivatives as Novel Potent Inhibitors of Protein Tyrosine Phosphatase 1B: Insight into the Inhibitory Mechanism through Molecular Modeling Studies.
    Qian M; Shan Y; Guan S; Zhang H; Wang S; Han W
    J Chem Inf Model; 2016 Oct; 56(10):2024-2034. PubMed ID: 27649447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.
    Wang JF; Gong K; Wei DQ; Li YX; Chou KC
    Protein Eng Des Sel; 2009 Jun; 22(6):349-55. PubMed ID: 19380334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B.
    Zhi Y; Gao LX; Jin Y; Tang CL; Li JY; Li J; Long YQ
    Bioorg Med Chem; 2014 Jul; 22(14):3670-83. PubMed ID: 24906513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and discerning interactions of PTP1B allosteric inhibitors: novel insights from molecular dynamics simulations.
    Shinde RN; Sobhia ME
    J Mol Graph Model; 2013 Sep; 45():98-110. PubMed ID: 24012873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
    Malla P; Kumar R; Kumar M
    Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
    Fang L; Zhang H; Cui W; Ji M
    J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity.
    Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H
    Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha7 helix plays an important role in the conformational stability of PTP1B.
    Olmez EO; Alakent B
    J Biomol Struct Dyn; 2011 Apr; 28(5):675-93. PubMed ID: 21294582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
    Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
    J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation.
    Liu WS; Wang RR; Sun YZ; Li WY; Li HL; Liu CL; Ma Y; Wang RL
    J Cell Biochem; 2019 Oct; 120(10):17015-17029. PubMed ID: 31125141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
    Chen X; Liu X; Gan Q; Feng C; Zhang Q
    Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches.
    Ramírez-Espinosa JJ; Rios MY; López-Martínez S; López-Vallejo F; Medina-Franco JL; Paoli P; Camici G; Navarrete-Vázquez G; Ortiz-Andrade R; Estrada-Soto S
    Eur J Med Chem; 2011 Jun; 46(6):2243-51. PubMed ID: 21453996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    J Biomol Struct Dyn; 2018 Nov; 36(14):3636-3650. PubMed ID: 29048995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors.
    Navarrete-Vazquez G; Ramírez-Martínez M; Estrada-Soto S; Nava-Zuazo C; Paoli P; Camici G; Escalante-García J; Medina-Franco JL; López-Vallejo F; Ortiz-Andrade R
    Eur J Med Chem; 2012 Jul; 53():346-55. PubMed ID: 22583779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.